Pulmicort inhalation and ambroxol treatment bronchiolitis.docVIP

 PAGE \* MERGEFORMAT 6 Pulmicort inhalation and ambroxol treatment bronchiolitis [Keywords:] ambroxol Pulmicort aerosol spray Mucosolvan Bronchiolitis (hereinafter referred to as bronchiolitis in infants and young children in winter and spring of the most common breathing disease, symptoms and longer duration, yet lack of specific treatment. Our department with Pulmicort (AstraZeneca Pharmaceuticals, Ambroxol injection (research pharmaceutical companies Boehringer Ingelheim, Germany, by the inhalation of air compression pump therapy, the effect is significant, are as follows. 1 Materials and Methods 1.1 General information with reference to the national control program in children with pneumonia, “the diagnostic criteria for bronchiolitis” [1], select the First People’s Hospital of Pediatrics in Changshu City, in November 2005 ~ March 2006 the hospital treated 60 patients with bronchiolitis, age 55 days to 11 months, of which lt;6 months 42 patients were randomly divided into two groups, treatment group, 30 patients, 21 males and 9 females, control group of 30 patients, 23 males and 7 females, both groups coughing, wheezing, shortness of breath, lungs and wheezing can be heard, small and medium moist rales. two children with gender, age, condition the difference was not statistically significant (Pgt; 0.05). 1.2 The treatment groups were used antibiotics, hormones, oxygen, asthma and other conventional therapy, with heart failure patient for cardiac, diuretic, vasodilator and other appropriate treatment. The treatment group, the treatment based on the use of Pulmicort Each 1 ml (containing budesonide 0.15 mg, Ambroxol 7.5 mg / second, compression pump (produced by the German Berry inhalation, 2 or 3 times a day, every inhalation of about 10 ~ 15 min, treatment 5 ~ 7 days. observe whether the adverse reaction during treatment. two sets of data by SPSS 11.0 statistical software, computer analysis. 2 Results 2.1 determine the effect of markedl